# Chen Qiyu

> Chen Qiyu is a Series B investor at Fosun International (Shanghai) backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Fosun International](https://shizune.co/investors/profile/fosun-international)
- Location: Shanghai, China
- Total investments: 1
- Last investment: Apr 2018
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/qiyu-chen/
- Website: https://en.fosun.com/content/details92_3188.html

Chen Qiyu is a Series B investor at Fosun International in Shanghai focused on Medical and Health Care. Mr. Chen Qiyu is the executive Director and co-CEO of Fosun International. Mr. Chen joined the group in April 1994 and was appointed as a Director in May 2005. Mr. Chen is the chairman of Fosun High Tech, an executive director and a co-chief executive officer of Fosun International, a non-executive director and vice chairman of Sinopharm, anon-executive director of Babytree Group and a non-executive director and chairman of the board of directors of Shanghai Henlius, all of which are companies listed on the Hong Kong Stock Exchange. My Chen Qiyu is also a director of Beijing Sanyuan Foods Co., Ltd., a company listed on the Shanghai Stock Exchange, and a co-chairman of the board of New Frontier Health Corporation, a company listed on the New York Stock Exchange. Mr. Chen was a director of Maxigen Biotech Inc., a company listed on the Taiwan Stock Exchange and a director of Di’an Diagnostics Group Co., Ltd., a company listed on the growth enterprise board of the Shenzhen Stock Exchange. Mr. Chen is the chairman of China Medical Pharmaceutical Material Association, vice president of China Pharmaceutical Industry Research and Development Association, honorary chairman and chief supervisor of the Shanghai Biopharmaceutical Industry Association, vice chairman of the Shanghai Society of Genetics and a member of the 13th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference. Mr. Chen obtained a bachelor degree in genetics from Fudan University in July 1993 and an executive master of business administration from China Europe International Business School in September 2005.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Medical Device | 1 | 100% |
| Machine Learning | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Airdoc | Harnessing the power of AI and our extensive machine-learned database of millions of annotated medical records, we provide software for diagnosis assistance, real-time medical image analysis, large-scale data mining of clinical and health data. Our highly accurate image diagnosis software works with images from eye, skin, brain, cardiovascular,lung, liver, bone, breast and more to quickly and reliably assist clinicians as well as all healthcare consumers. |  | Series B | Apr 02, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [Sogou](https://shizune.co/investors/profile/sogou) — VC Fund, 1 deal together

## About Fosun International

VC Fund · Shanghai, China

Fosun International Limited is a Hong Kong-based investment holding company engaged in financial, property, steel, and healthcare businesses. The Company has nine segments. Insurance operates and invests in insurance businesses. Investment is engaged in strategic investment, private equity investment, venture capital investment, and secondarymarket investment.Fosun International Limited was founded in 1992.

5 contacts available at Fosun International.

| Name | Title | Profile |
| --- | --- | --- |
| Chen Qiyu | Ecutive Director & Co-CEO | https://shizune.co/investors/profile/chen-qiyu |
| Cong Yonggang | Vice President & Managing Director | https://shizune.co/investors/profile/cong-yonggang |
| Ding Guoqi | SVP & CFO | https://shizune.co/investors/profile/ding-guoqi |
| Qin Xuetang | Executive Director & Senior Vice President | https://shizune.co/investors/profile/qin-xuetang |
| Wang Qunbin | Board of Directors and Co-chairman | https://shizune.co/investors/profile/wang-qunbin |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Chen Qiyu invest in?

Chen Qiyu invests primarily in Medical, Health Care and Medical Device startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chen Qiyu last invest?

The most recent investment recorded for Chen Qiyu closed in Apr 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co